Researchers from University of Waterloo Report New Studies and Findings in the Area of Obesity, Fitness and Wellness [Consumer Mobile Apps for Potential Drug-Drug Interaction Check: Systematic Review and Content Analysis Using the Mobile App ...]
By a News Reporter-Staff News Editor at Telemedicine Business Week -- A new study on Obesity, Fitness and Wellness is now available. According to news reporting out of Waterloo, Canada, by NewsRx editors, research stated, “General consumers can now easily access drug information and quickly check for potential drug-drug interactions (PDDIs) through mobile health (mHealth) apps. With aging population in Canada, more people have chronic diseases and comorbidities leading to increasing numbers of medications.”
Our news journalists obtained a quote from the research from the University of Waterloo, “The use of mHealth apps for checking PDDIs can be helpful in ensuring patient safety and empowerment. The aim of this study was to review the characteristics and quality of publicly available mHealth apps that check for PDDIs. Apple App Store and Google Play were searched to identify apps with PDDI functionality. The apps’ general and feature characteristics were extracted. The Mobile App Rating Scale (MARS) was used to assess the quality. A total of 23 apps were included for the review-12 from Apple App Store and 11 from Google Play. Only 5 of these were paid apps, with an average price of $7.19 CAD. The mean MARS score was 3.23 out of 5 (interquartile range 1.34). The mean MARS scores for the apps from Google Play and Apple App Store were not statistically different (p=.84). The information dimension was associated with the highest score (3.63), whereas the engagement dimension resulted in the lowest score (2.75). The total number of features per app, average rating, and price were significantly associated with the total MARS score. Some apps provided accurate and comprehensive information about potential adverse drug effects from PDDIs. Given the potentially severe consequences of incorrect drug information, there is a need for oversight to eliminate low quality and potentially harmful apps.”
According to the news editors, the research concluded: “Because managing PDDIs is complex in the absence of complete information, secondary features such as medication reminder, refill reminder, medication history tracking, and pill identification could help enhance the effectiveness of PDDI apps.”
For more information on this research see: Consumer Mobile Apps for Potential Drug-Drug Interaction Check: Systematic Review and Content Analysis Using the Mobile App Rating Scale (MARS). Jmir Mhealth and Uhealth , 2018;6(3):e74.
Our news journalists report that additional information may be obtained by contacting B.Y. Kim, Health Data Science Lab, School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada. Additional authors for this research include A. Sharafoddini, N. Tran, E.Y. Wen and J. Lee.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.2196/mhealth.8613. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-04-18), Researchers from University of Waterloo Report New Studies and Findings in the Area of Obesity, Fitness and Wellness [Consumer Mobile Apps for Potential Drug-Drug Interaction Check: Systematic Review and Content Analysis Using the Mobile App ...], Telemedicine Business Week, 26, ISSN: 1553-3433, BUTTER® ID: 015484154
From the newsletter Telemedicine Business Week.
https://www.newsrx.com/Butter/#!Search:a=15484154
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.